[Federal Register Volume 84, Number 114 (Thursday, June 13, 2019)] [Notices] [Page 27659] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2019-12503] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 12, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on March 7, 2019, Sigma Aldrich Research, Biochemicals, Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Cathinone................................ 1235 I Mephedrone (4-Methyl-N-methylcathinone).. 1248 I Lysergic acid diethylamide............... 7315 I Tetrahydrocannabinols.................... 7370 I 3,4-Methylenedioxymethamphetamine........ 7405 I Alpha-methyltryptamine................... 7432 I Dimethyltryptamine....................... 7435 I 5-Methoxy-N,N-diisopropyltryptamine...... 7439 I N-Benzylpiperazine....................... 7493 I 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) 7517 I MDPV (3,4-Methylenedioxypyrovalerone).... 7535 I Methylone (3,4-Methylenedioxy-N- 7540 I methylcathinone). Heroin................................... 9200 I Normorphine.............................. 9313 I Norlevorphanol........................... 9634 I Amphetamine.............................. 1100 II Nabilone................................. 7379 II Phencyclidine............................ 7471 II Cocaine.................................. 9041 II Codeine.................................. 9050 II Ecgonine................................. 9180 II Levorphanol.............................. 9220 II Meperidine............................... 9230 II Methadone................................ 9250 II Morphine................................. 9300 II Thebaine................................. 9333 II Levo-alphacetylmethadol.................. 9648 II Noroxymorphone........................... 9668 II Remifentanil............................. 9739 II Sufentanil............................... 9740 II Carfentanil.............................. 9743 II Fentanyl................................. 9801 II ------------------------------------------------------------------------ The company plans to manufacture reference standards. Dated: June 3, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019-12503 Filed 6-12-19; 8:45 am] BILLING CODE 4410-09-P
Publication Title | Federal Register Volume 84, Issue 114 (June 13, 2019) |
Category | Regulatory Information |
Collection | Federal Register |
SuDoc Class Number | AE 2.7: GS 4.107: AE 2.106: |
Publisher | Office of the Federal Register, National Archives and Records Administration |
Section | Notices |
Action | Notice of application. |
Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before August 12, 2019. |
Agency Names | DEPARTMENT OF JUSTICE Drug Enforcement Administration |
Page Number Range | 27659-27659 |
Federal Register Citation | 84 FR 27659 |
Docket Numbers | Docket No. DEA-392 |
FR Doc Number | 2019-12503 |
fetchChildrenOnly | 1 |
granuleId | 2019-12503 |
digitizedFR | false |
showPublinkTab | false |
packageId | FR-2019-06-13 |
agencies | Justice Department;Drug Enforcement Administration |
browsePath | 2019/06/06-13\/5 |